The <scp>BACE</scp> ‐1 inhibitor <scp>CNP</scp> 520 for prevention trials in Alzheimer's disease
2018 · EMBO Molecular Medicine · 167 citations
https://doi.org/10.15252/emmm.201809316
V
Valérie Dubost
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.0K
Citations
15
h-index
17
i10-index
Valérie Dubost is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Epigenetics and DNA Methylation & MicroRNA in disease regulation & Multiple Sclerosis Research Studies. The author has an h-index of 15, co-authored 30 publications.
Papers by this author
worksEvaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells
2021 · Molecular Therapy — Methods & Clinical Development · 17 citations
https://doi.org/10.1016/j.omtm.2021.09.004
Characterizing Antisense Oligonucleotide-Induced Histopathology Findings in Spinal Cord of Mauritius Cynomolgus Monkeys by Molecular Localization Investigation
2025 · Toxicologic Pathology · 2 citations
https://doi.org/10.1177/01926233241311277
Disruption of serotonin homeostasis in intestinal organoids provides insights into drug-induced gastrointestinal toxicity
2024 · Toxicology · 0 citations
https://doi.org/10.1016/j.tox.2024.154028
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat